What does APOTHEEK AELTERMAN L. do?

APOTHEEK AELTERMAN L. is a pharmacy in Halle. Private Limited, started on 11 July 2019, 1 establishment.

What is the address of APOTHEEK AELTERMAN L.?

The registered office of APOTHEEK AELTERMAN L. is located at Edingensesteenweg 699, 1502 Halle.

Is APOTHEEK AELTERMAN L. still active?

Yes. According to the CBE (30 September 2026) APOTHEEK AELTERMAN L. is active, legal situation “Normale toestand”, started on 11 July 2019.

Is APOTHEEK AELTERMAN L. registered on Peppol?

Yes, APOTHEEK AELTERMAN L. is registered on the Peppol network with ID 0208:0730614787.

What is the enterprise number of APOTHEEK AELTERMAN L.?

The enterprise number of APOTHEEK AELTERMAN L. is BE0730614787.

When was APOTHEEK AELTERMAN L. founded?

APOTHEEK AELTERMAN L. was founded on 11 July 2019.

Who are the directors of APOTHEEK AELTERMAN L.?

According to the 2025 annual accounts, the directors of APOTHEEK AELTERMAN L. are: Luc Aelterman, Leen Aelterman.

Is APOTHEEK AELTERMAN L. a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 July 2019; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK AELTERMAN L. make in 2025?

APOTHEEK AELTERMAN L. posted a profit after taxes of € 107,750 in financial year 2025.

What is the revenue of APOTHEEK AELTERMAN L.?

As a small company, APOTHEEK AELTERMAN L. is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 224,136.

How many employees does APOTHEEK AELTERMAN L. have?

According to the 2025 annual accounts, APOTHEEK AELTERMAN L. has 0 full-time equivalents (FTE).

APOTHEEK AELTERMAN L. (Private Limited) - Halle

Dossier APOTHEEK AELTERMAN L., printed on 30 September 2026 from databakkes.be/en/0730614787/apotheek-aelterman-l. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK AELTERMAN L. from Halle, company number BE0730614787, closed financial year 2025 with a result of € 107,750 after tax. For that financial year APOTHEEK AELTERMAN L. recorded a gross margin of € 224,136 and equity of € 230,991. Compared with financial year 2024, the result moved from € 87,773 to € 107,750. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 22, 2026.

What it is worth Growing

€ 230,991

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 107,750

▲ 23% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 171,662

▲ 91% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 107,700 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 55,198

▲ 1% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,230

▼ 54% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 89,116

▼ 20% vs 2024

€ 22,895 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 26,949

▼ 18% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 39,797

▲ 18% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 137,669 Gross margin 2022: € 137,669 First fiscal year in the series	€ 167,727 Gross margin 2023: € 167,727 ▲ 22% vs 2022 (€ 137,669) Favourable step	€ 202,228 Gross margin 2024: € 202,228 ▲ 21% vs 2023 (€ 167,727) Favourable step	€ 224,136 Gross margin 2025: € 224,136 ▲ 11% vs 2024 (€ 202,228) Favourable step	▲ 11%
Profit after taxes	€ 74,132 Profit after taxes 2022: € 74,132 First fiscal year in the series	€ 90,827 Profit after taxes 2023: € 90,827 ▲ 23% vs 2022 (€ 74,132) Favourable step	€ 87,773 Profit after taxes 2024: € 87,773 ▼ 3% vs 2023 (€ 90,827) Unfavourable step	€ 107,750 Profit after taxes 2025: € 107,750 ▲ 23% vs 2024 (€ 87,773) Favourable step	▲ 23%
Equity	€ 230,941 Equity 2022: € 230,941 First fiscal year in the series	€ 230,941 Equity 2023: € 230,941 Unchanged (€ 230,941) Unchanged	€ 230,941 Equity 2024: € 230,941 Unchanged (€ 230,941) Unchanged	€ 230,991 Equity 2025: € 230,991 Unchanged (€ 230,941) Favourable step
Total debts	€ 285,641 Total debts 2022: € 285,641 First fiscal year in the series	€ 351,981 Total debts 2023: € 351,981 ▲ 23% vs 2022 (€ 285,641) Unfavourable step	€ 331,031 Total debts 2024: € 331,031 ▼ 6% vs 2023 (€ 351,981) Favourable step	€ 401,362 Total debts 2025: € 401,362 ▲ 21% vs 2024 (€ 331,031) Unfavourable step	▲ 21%
Cash	€ 201,344 Cash 2022: € 201,344 First fiscal year in the series	€ 307,642 Cash 2023: € 307,642 ▲ 53% vs 2022 (€ 201,344) Favourable step	€ 89,931 Cash 2024: € 89,931 ▼ 71% vs 2023 (€ 307,642) Unfavourable step	€ 171,662 Cash 2025: € 171,662 ▲ 91% vs 2024 (€ 89,931) Favourable step	▲ 91%
Land & buildings	-	-	-	€ 3,612 Land & buildings 2025: € 3,612 First fiscal year in the series
Retained profit	€ 220,941 Retained profit 2022: € 220,941 First fiscal year in the series	€ 220,941 Retained profit 2023: € 220,941 Unchanged (€ 220,941) Unchanged	€ 220,941 Retained profit 2024: € 220,941 Unchanged (€ 220,941) Unchanged	€ 220,991 Retained profit 2025: € 220,991 Unchanged (€ 220,941) Favourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 90,827 Dividend 2023: € 90,827 Unchanged (€ 0) Unchanged	€ 87,773 Dividend 2024: € 87,773 ▼ 3% vs 2023 (€ 90,827) Unchanged	€ 107,700 Dividend 2025: € 107,700 ▲ 23% vs 2024 (€ 87,773) Unchanged	▲ 23%
Bank debt	€ 156,346 Bank debt 2022: € 156,346 First fiscal year in the series	€ 134,176 Bank debt 2023: € 134,176 ▼ 14% vs 2022 (€ 156,346) Favourable step	€ 111,767 Bank debt 2024: € 111,767 ▼ 17% vs 2023 (€ 134,176) Favourable step	€ 89,116 Bank debt 2025: € 89,116 ▼ 20% vs 2024 (€ 111,767) Favourable step	▼ 20%
Balance sheet total	€ 516,582 Balance sheet total 2022: € 516,582 First fiscal year in the series	€ 582,922 Balance sheet total 2023: € 582,922 ▲ 13% vs 2022 (€ 516,582) Unchanged	€ 561,972 Balance sheet total 2024: € 561,972 ▼ 4% vs 2023 (€ 582,922) Unchanged	€ 632,353 Balance sheet total 2025: € 632,353 ▲ 13% vs 2024 (€ 561,972) Unchanged	▲ 13%

Key figures of APOTHEEK AELTERMAN L., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK AELTERMAN L.?

What happened at APOTHEEK AELTERMAN L. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 22, 2026 New annual accounts for financial year 2025: profit of € 107,750 (▲ 23% vs 2024). Source: NBB ↗
2024 Luc Aelterman became a director. NBB
Jul 11, 2019 New establishment in Halle. KBO
2019 Leen Aelterman became a director. NBB
Jul 11, 2019 Start of the company according to the CBE. KBO

In short

From € 74,132 profit in 2022 to € 107,750 profit in 2025.

Paid € 106,762 in corporate taxes since 2022.

Best year ever: 2025, with € 107,750 profit.

Paid out € 286,300 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at APOTHEEK AELTERMAN L.? We notify you, reason included.

Follow APOTHEEK AELTERMAN L.

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit